Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).
Sesmilo G, Gaztambide S, Venegas E, Picó A, Del Pozo C, Blanco C, Torres E, Álvarez-Escolà C, Fajardo C, García R, Cámara R, Bernabeu I, Soto A, Villabona C, Serraclara A, Halperin I, Alcázar V, Palomera E, Webb SM; REA investigators. Sesmilo G, et al. Among authors: bernabeu i. Pituitary. 2013 Mar;16(1):115-21. doi: 10.1007/s11102-012-0384-x. Pituitary. 2013. PMID: 22481632
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy.
Marazuela M, Lucas T, Alvarez-Escolá C, Puig-Domingo M, de la Torre NG, de Miguel-Novoa P, Duran-Hervada A, Manzanares R, Luque-Ramírez M, Halperin I, Casanueva FF, Bernabeu I. Marazuela M, et al. Among authors: bernabeu i. Eur J Endocrinol. 2009 Apr;160(4):535-42. doi: 10.1530/EJE-08-0705. Epub 2009 Jan 15. Eur J Endocrinol. 2009. PMID: 19147599
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study.
Marazuela M, Paniagua AE, Gahete MD, Lucas T, Alvarez-Escolá C, Manzanares R, Cameselle-Teijeiro J, Luque-Ramirez M, Luque RM, Fernandez-Rodriguez E, Castaño JP, Bernabeu I. Marazuela M, et al. Among authors: bernabeu i. J Clin Endocrinol Metab. 2011 Feb;96(2):E251-9. doi: 10.1210/jc.2010-1742. Epub 2010 Nov 10. J Clin Endocrinol Metab. 2011. PMID: 21068147
Pegvisomant and cabergoline combination therapy in acromegaly.
Bernabeu I, Alvarez-Escolá C, Paniagua AE, Lucas T, Pavón I, Cabezas-Agrícola JM, Casanueva FF, Marazuela M. Bernabeu I, et al. Pituitary. 2013 Mar;16(1):101-8. doi: 10.1007/s11102-012-0382-z. Pituitary. 2013. PMID: 22396133
[Neuroendocrinology in 2011].
Puig Domingo M, Castaño J, Alvarez-Escolá C, Resmini E, Venegas E, García Arnés J, Torres E, Lecumberri B, Barahona MJ, Lamas C, Fajardo C, Cámara R, Vicente A, Blanco C, Villabona C, Del Pozo C, Halperin I, Salinas I, Sesmilo G, Aller J, Marazuela M, Webb SM, Bernabeu I. Puig Domingo M, et al. Among authors: bernabeu i. Endocrinol Nutr. 2012 May;59(5):311-25. doi: 10.1016/j.endonu.2012.01.009. Epub 2012 Mar 16. Endocrinol Nutr. 2012. PMID: 22425316 Spanish. No abstract available.
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues.
Oriola J, Lucas T, Halperin I, Mora M, Perales MJ, Alvarez-Escolá C, Paz de MN, Díaz Soto G, Salinas I, Julián MT, Olaizola I, Bernabeu I, Marazuela M, Puig-Domingo M. Oriola J, et al. Among authors: bernabeu i. Eur J Endocrinol. 2012 Dec 10;168(1):9-13. doi: 10.1530/EJE-12-0457. Print 2013 Jan. Eur J Endocrinol. 2012. PMID: 23038625
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study.
Sesmilo G, Resmini E, Bernabeu I, Aller J, Soto A, Mora M, Picó A, Fajardo C, Torres E, Alvarez-Escolá C, García R, Blanco C, Cámara R, Gaztambide S, Salinas I, Pozo CD, Castells I, Villabona C, Biagetti B, Webb SM. Sesmilo G, et al. Among authors: bernabeu i. Clin Endocrinol (Oxf). 2014 Dec;81(6):883-90. doi: 10.1111/cen.12440. Epub 2014 Mar 19. Clin Endocrinol (Oxf). 2014. PMID: 24612232
73 results